RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2025)
RedHill Biopharma's (RDHL) quarterly Other Non-Current Liabilities came in at $456000.0 in Q4 2025, down 56.86% quarter-over-quarter from $1.1 million in Q4 2016.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Other Non-Current Liabilities for 7 consecutive years, with $456000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $456000.0 in Q4 2025; TTM through Dec 2025 was $456000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $456000.0, changed N/A from the prior year.
- Other Non-Current Liabilities was $456000.0 for Q4 2025 at RedHill Biopharma, down from $1.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $456000.0 in Q4 2025 and troughed at $456000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 456,000.00 |
| Dec 31, 2016 | 1.06 Mn |
| Sep 30, 2016 | 1.06 Mn |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 1.06 Mn |
| Dec 31, 2015 | 1.06 Mn |
| Sep 30, 2015 | 1.06 Mn |
| Jun 30, 2015 | 1.06 Mn |
| Mar 31, 2015 | 1.06 Mn |
| Dec 31, 2014 | 1.53 Mn |
| Sep 30, 2014 | 1.53 Mn |
| Jun 30, 2014 | 1.53 Mn |
| Mar 31, 2014 | 1.59 Mn |
| Dec 31, 2013 | 1.87 Mn |
| Sep 30, 2013 | 2.50 Mn |
| Jun 30, 2013 | 3.23 Mn |
| Mar 31, 2013 | 3.26 Mn |
| Dec 31, 2012 | 3.27 Mn |
| Dec 31, 2011 | 2.69 Mn |